Eivatech is a company created since 2012 that valorizes an invention of antibody library screening.
We are fully dedicated to our projects and clients.
Eivatech, a company specialized in immunotechnologies , offers high value-added solutions for the custom development of antibodies. The company supports its clients by offering them tailor-made solutions for their R&D, Diagnostic and Therapeutic projects.
From the generation of unique monoclonal antibodies by our proprietary antibody library screening at high efficiency through their production, characterization (affinity constants determinations and specificity studies, sequencing, …) Eivatech offers a wide range of customized services.
Confidentiality & Results property
Eivatech is pledged by contract not to reveal any information concerning the projects carried out and not to disclose the identity of its clients without having obtained their consent beforehand. From the first discussions, a Non-Disclosure Agreement can be signed upon request. Eivatech does notclaim any intellectual property or other rights on results obtained in the framework of fee-for-service projects.
No claim, No royalty, No follow-up righ